The first goal in the FDA Medical Countermeasures Initiative (MCMi) strategic plan (PDF, 632 KB) is “Develop and maintain the highly qualified workforce with appropriate technical training, scientific skill, and subject‐matter expertise, and improve infrastructure at FDA... so that the MCMi workforce has the tools required to succeed.”
Through professional development, FDA meets the regulatory challenges posed by new science and technology developments. In addition to supporting a broad regulatory science program—including professional development components—FDA fosters collaborative activities with scientific institutions, academia, and industry. Key professional development activities include:
- MCMi Lectures: MCMi supports lectures that cover a range of topics including guidance development, the policies, procedures, and framework for assessing applications for review, and other timely MCM topics.
- Additional MCM Education Opportunities: FDA encourages staff to further their MCM education through specialized training, and by offering continuing education credits.
- MCMi Regulatory Science Symposium: MCMi has sponsored Regulatory Science Symposia to exchange ideas on MCM development and explore the latest research.
- Advancing skills of FDA staff: FDA recruits and fosters top talent by providing innovative skill development programs to prepare staff to successfully address the regulatory challenges presented by new areas of science and medicine.
FDA hosts numerous public meetings and workshops each year. For MCM-related events, visit our News and Events page.
Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures and emerging infectious diseases.